Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door

Detalles Bibliográficos
Autores principales: Yang, Y. Tony, Chen, Brian, Bennett, Charles L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Comments and Controversies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366246/
https://www.ncbi.nlm.nih.gov/pubmed/27998222
http://dx.doi.org/10.1200/JCO.2016.68.2989
_version_ 1783393586300059648
author Yang, Y. Tony
Chen, Brian
Bennett, Charles L.
author_facet Yang, Y. Tony
Chen, Brian
Bennett, Charles L.
author_sort Yang, Y. Tony
collection PubMed
description
format Online
Article
Text
id pubmed-6366246
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-63662462019-02-14 Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door Yang, Y. Tony Chen, Brian Bennett, Charles L. J Clin Oncol Comments and Controversies American Society of Clinical Oncology 2016-12-20 2016-10-03 /pmc/articles/PMC6366246/ /pubmed/27998222 http://dx.doi.org/10.1200/JCO.2016.68.2989 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/
spellingShingle Comments and Controversies
Yang, Y. Tony
Chen, Brian
Bennett, Charles L.
Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title_full Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title_fullStr Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title_full_unstemmed Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title_short Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door
title_sort federal 340b program payment scheme for drugs designated as orphan products: congressional clarification needed to close the government-industry revolving door
topic Comments and Controversies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366246/
https://www.ncbi.nlm.nih.gov/pubmed/27998222
http://dx.doi.org/10.1200/JCO.2016.68.2989
work_keys_str_mv AT yangytony federal340bprogrampaymentschemefordrugsdesignatedasorphanproductscongressionalclarificationneededtoclosethegovernmentindustryrevolvingdoor
AT chenbrian federal340bprogrampaymentschemefordrugsdesignatedasorphanproductscongressionalclarificationneededtoclosethegovernmentindustryrevolvingdoor
AT bennettcharlesl federal340bprogrampaymentschemefordrugsdesignatedasorphanproductscongressionalclarificationneededtoclosethegovernmentindustryrevolvingdoor

Ejemplares similares